Stimcell Energetics INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
Stimcell Energetics Inc. reported a significant increase in net loss for fiscal year 2025, alongside a restart of eBalance device redesign and ongoing reliance on related-party financing.
OQB
10-K: Cell MedX Corp. Reports Fiscal Year 2024 Results Amidst Financial Challenges and Strategic Shift
Cell MedX Corp.'s annual report reveals a year of financial difficulties, including suspended operations and a significant debt conversion, alongside a strategic shift away from active research and development.